Improving Hallucinations by Targeting the RSTS with TES
Launched by BETH ISRAEL DEACONESS MEDICAL CENTER · Dec 14, 2021
Trial Information
Current as of July 01, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a new way to help people who experience hallucinations, particularly those who hear voices or see things that aren't there. Researchers believe that a specific area in the brain called the right superior temporal sulcus (rSTS) plays a key role in these hallucinations. They want to see if a type of non-invasive brain stimulation can improve brain function in this area, which may help reduce the frequency and severity of hallucinations.
To participate in this study, you need to be between 18 and 50 years old, speak English well, and currently be experiencing hallucinations. It's important that you haven’t recently undergone other similar treatments. If you join the study, you will receive the brain stimulation therapy, and researchers will monitor your progress. They are looking for individuals of all genders who are actively dealing with these challenges, so this trial could be an opportunity to explore a new treatment option that might make a difference in your daily life.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Aged 18-50 years of age
- • 2. Proficient in English
- • 3. Able to give informed consent
- • 4. Actively experiencing hallucinations (tactile, auditory, visual, etc.)
- • 5. Has not recently participated in tES/TMS treatments
- Exclusion Criteria:
- • 1. Substance abuse or dependence (w/in past 6 months)
- • 2. Those who are pregnant/breastfeeding
- • 3. History of head injury with \> 15 minutes of loss of consciousness/mal sequelae
- • 4. DSM-V intellectual disability
- • 5. Having a non-removable ferromagnetic metal within the body (particularly in the head)
- • 6. History of seizures
About Beth Israel Deaconess Medical Center
Beth Israel Deaconess Medical Center (BIDMC) is a leading academic medical center located in Boston, Massachusetts, affiliated with Harvard Medical School. Renowned for its commitment to cutting-edge research and innovation in healthcare, BIDMC fosters a collaborative environment that integrates patient care, education, and scientific investigation. The center actively sponsors clinical trials across a variety of disciplines, aiming to advance medical knowledge and improve patient outcomes. With a focus on translational medicine, BIDMC's research initiatives engage multidisciplinary teams to address complex health challenges and translate findings into effective therapeutic strategies.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Boston, Massachusetts, United States
Patients applied
Trial Officials
Paulo Lizano, MD, PhD
Principal Investigator
Beth Israel Deaconess Medical Center
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials